Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 63

1.

Employing the Payback Framework to Assess Implementation Science Research Utilization: Lessons From the USAID's PEPFAR HIV/AIDS Implementation Science Awards.

Castor D, Kimmel AL, McFall A, Padian N, Yansaneh A, Wiant S, Sandison S, Holmes C, Lucas R, Stanton D, Goosby E, Kottiri B.

J Acquir Immune Defic Syndr. 2019 Dec;82 Suppl 3:S348-S356. doi: 10.1097/QAI.0000000000002226.

PMID:
31764273
2.

The only way is up: priorities for implementing long-acting antiretrovirals for HIV prevention and treatment.

Castor D, Meyers K, Allen S.

Curr Opin HIV AIDS. 2020 Jan;15(1):73-80. doi: 10.1097/COH.0000000000000601.

PMID:
31688333
3.

Use and Acceptability of HIV Self-Testing Among First-Time Testers at Risk for HIV in Senegal.

Lyons CE, Coly K, Bowring AL, Liestman B, Diouf D, Wong VJ, Turpin G, Castor D, Dieng P, Olawore O, Geibel S, Ketende S, Ndour C, Thiam S, Touré-Kane C, Baral SD.

AIDS Behav. 2019 Sep;23(Suppl 2):130-141. doi: 10.1007/s10461-019-02552-2.

4.

Characterizing the Influence of Structural Determinants of HIV Risk on Consistent Condom Use Among Female Sex Workers in Senegal.

Twahirwa Rwema JO, Lyons CE, Ketende S, Bowring AL, Rao A, Comins C, Diouf D, Drame FM, Liestman B, Coly K, Ndour C, Turpin G, Mboup S, Toure-Kane C, Castor D, Leye-Diouf N, Diop-Ndiaye H, Baral S.

J Acquir Immune Defic Syndr. 2019 May 1;81(1):63-71. doi: 10.1097/QAI.0000000000001991.

PMID:
30865185
5.

Superior effect of MP-AzeFlu than azelastine or fluticasone propionate alone on reducing inflammatory markers.

Roca-Ferrer J, Pujols L, Pérez-González M, Alobid I, Callejas B, Vicens-Artés S, Fuentes M, Valero A, Picado C, Castor D, Nguyen D, Mullol J.

Allergy Asthma Clin Immunol. 2018 Dec 18;14:86. doi: 10.1186/s13223-018-0311-4. eCollection 2018.

6.

Cluster randomized trial of comprehensive gender-based violence programming delivered through the HIV/AIDS program platform in Mbeya Region, Tanzania: Tathmini GBV study.

Settergren SK, Mujaya S, Rida W, Kajula LJ, Kamugisha H, Kilonzo Mbwambo J, Kisanga F, Mizinduko MM, Dunbar MS, Mwandalima I, Wazee H, Prieto D, Mullick S, Erie J, Castor D.

PLoS One. 2018 Dec 6;13(12):e0206074. doi: 10.1371/journal.pone.0206074. eCollection 2018.

7.

Understanding and measuring uptake and coverage of oral pre-exposure prophylaxis delivery among adolescent girls and young women in sub-Saharan Africa.

Dunbar MS, Kripke K, Haberer J, Castor D, Dalal S, Mukoma W, Mullick S, Patel P, Reed J, Subedar H, Were D, Warren M, Torjesen K.

Sex Health. 2018 Nov;15(6):513-521. doi: 10.1071/SH18061. Review.

8.

Noncanonical Mismatch Repair as a Source of Genomic Instability in Human Cells.

Peña-Diaz J, Bregenhorn S, Ghodgaonkar M, Follonier C, Artola-Borán M, Castor D, Lopes M, Sartori AA, Jiricny J.

Mol Cell. 2017 Jul 6;67(1):162. doi: 10.1016/j.molcel.2017.06.026. No abstract available.

9.

Correction: Age Targeting of Voluntary Medical Male Circumcision Programs Using the Decision Makers' Program Planning Toolkit (DMPPT) 2.0.

Kripke K, Opuni M, Schnure M, Sgaier S, Castor D, Reed J, Njeuhmeli E, Stover J.

PLoS One. 2017 Mar 16;12(3):e0174466. doi: 10.1371/journal.pone.0174466. eCollection 2017.

10.

Correction: Voluntary Medical Male Circumcision for HIV Prevention in Malawi: Modeling the Impact and Cost of Focusing the Program by Client Age and Geography.

Kripke K, Chimbwandira F, Mwandi Z, Matchere F, Schnure M, Reed J, Castor D, Sgaier S, Njeuhmeli E.

PLoS One. 2017 Jan 3;12(1):e0169708. doi: 10.1371/journal.pone.0169708. eCollection 2017.

11.

Correction: Cost and Impact of Voluntary Medical Male Circumcision in South Africa: Focusing the Program on Specific Age Groups and Provinces.

Kripke K, Chen PA, Vazzano A, Thambinayagam A, Pillay Y, Loykissoonlal D, Bonnecwe C, Barron P, Kiwango E, Castor D, Njeuhmeli E.

PLoS One. 2017 Jan 3;12(1):e0169802. doi: 10.1371/journal.pone.0169802. eCollection 2017.

12.

Correction: Voluntary Medical Male Circumcision for HIV Prevention in Swaziland: Modeling the Impact of Age Targeting.

Kripke K, Okello V, Maziya V, Benzerga W, Mirira M, Gold E, Schnure M, Sgaier S, Castor D, Reed J, Njeuhmeli E.

PLoS One. 2017 Jan 3;12(1):e0169697. doi: 10.1371/journal.pone.0169697. eCollection 2017.

13.

Correction: Modeling the Impact of Uganda's Safe Male Circumcision Program: Implications for Age and Regional Targeting.

Kripke K, Vazzano A, Kirungi W, Musinguzi J, Opio A, Ssempebwa R, Nakawunde S, Kyobutungi S, Akao JN, Magala F, Mwidu G, Castor D, Njeuhmeli E.

PLoS One. 2017 Jan 3;12(1):e0169699. doi: 10.1371/journal.pone.0169699. eCollection 2017.

14.

Potential Impact of Integrated Stigma Mitigation Interventions in Improving HIV/AIDS Service Delivery and Uptake for Key Populations in Senegal.

Lyons CE, Ketende S, Diouf D, Drame FM, Liestman B, Coly K, Ndour C, Turpin G, Mboup S, Diop K, Toure-Kane C, Castor D, Leye-Diouf N, Baral S.

J Acquir Immune Defic Syndr. 2017 Jan 1;74 Suppl 1:S52-S59.

15.

Data and methods to characterize the role of sex work and to inform sex work programs in generalized HIV epidemics: evidence to challenge assumptions.

Mishra S, Boily MC, Schwartz S, Beyrer C, Blanchard JF, Moses S, Castor D, Phaswana-Mafuya N, Vickerman P, Drame F, Alary M, Baral SD.

Ann Epidemiol. 2016 Aug;26(8):557-569. doi: 10.1016/j.annepidem.2016.06.004. Epub 2016 Jun 15. Review.

16.

Age Targeting of Voluntary Medical Male Circumcision Programs Using the Decision Makers' Program Planning Toolkit (DMPPT) 2.0.

Kripke K, Opuni M, Schnure M, Sgaier S, Castor D, Reed J, Njeuhmeli E, Stover J.

PLoS One. 2016 Jul 13;11(7):e0156909. doi: 10.1371/journal.pone.0156909. eCollection 2016. Erratum in: PLoS One. 2017 Mar 16;12 (3):e0174466.

17.

Voluntary Medical Male Circumcision for HIV Prevention in Swaziland: Modeling the Impact of Age Targeting.

Kripke K, Okello V, Maziya V, Benzerga W, Mirira M, Gold E, Schnure M, Sgaier S, Castor D, Reed J, Njeuhmeli E.

PLoS One. 2016 Jul 13;11(7):e0156776. doi: 10.1371/journal.pone.0156776. eCollection 2016. Erratum in: PLoS One. 2017 Jan 3;12 (1):e0169697.

18.

Voluntary Medical Male Circumcision for HIV Prevention in Malawi: Modeling the Impact and Cost of Focusing the Program by Client Age and Geography.

Kripke K, Chimbwandira F, Mwandi Z, Matchere F, Schnure M, Reed J, Castor D, Sgaier S, Njeuhmeli E.

PLoS One. 2016 Jul 13;11(7):e0156521. doi: 10.1371/journal.pone.0156521. eCollection 2016. Erratum in: PLoS One. 2017 Jan 3;12 (1):e0169708.

19.

The Economic and Epidemiological Impact of Focusing Voluntary Medical Male Circumcision for HIV Prevention on Specific Age Groups and Regions in Tanzania.

Kripke K, Perales N, Lija J, Fimbo B, Mlanga E, Mahler H, Juma JM, Baingana E, Plotkin M, Kakiziba D, Semini I, Castor D, Njeuhmeli E.

PLoS One. 2016 Jul 13;11(7):e0153363. doi: 10.1371/journal.pone.0153363. eCollection 2016.

20.

Modeling the Impact of Uganda's Safe Male Circumcision Program: Implications for Age and Regional Targeting.

Kripke K, Vazzano A, Kirungi W, Musinguzi J, Opio A, Ssempebwa R, Nakawunde S, Kyobutungi S, Akao JN, Magala F, Mwidu G, Castor D, Njeuhmeli E.

PLoS One. 2016 Jul 13;11(7):e0158693. doi: 10.1371/journal.pone.0158693. eCollection 2016. Erratum in: PLoS One. 2017 Jan 3;12 (1):e0169699.

21.

Cost and Impact of Voluntary Medical Male Circumcision in South Africa: Focusing the Program on Specific Age Groups and Provinces.

Kripke K, Chen PA, Vazzano A, Thambinayagam A, Pillay Y, Loykissoonlal D, Bonnecwe C, Barron P, Kiwango E, Castor D, Njeuhmeli E.

PLoS One. 2016 Jul 13;11(7):e0157071. doi: 10.1371/journal.pone.0157071. eCollection 2016. Erratum in: PLoS One. 2017 Jan 3;12 (1):e0169802.

22.

Karyomegalic interstitial nephritis and DNA damage-induced polyploidy in Fan1 nuclease-defective knock-in mice.

Lachaud C, Slean M, Marchesi F, Lock C, Odell E, Castor D, Toth R, Rouse J.

Genes Dev. 2016 Mar 15;30(6):639-44. doi: 10.1101/gad.276287.115.

23.

Chromosome Missegregation Associated with RUVBL1 Deficiency.

Gentili C, Castor D, Kaden S, Lauterbach D, Gysi M, Steigemann P, Gerlich DW, Jiricny J, Ferrari S.

PLoS One. 2015 Jul 22;10(7):e0133576. doi: 10.1371/journal.pone.0133576. eCollection 2015.

24.

Association between intoxication at last sexual intercourse and unprotected sex among men and women in Uganda.

Kerridge BT, Castor D, Tran P, Barnhart M, Pickering R.

J Infect Dev Ctries. 2014 Nov 13;8(11):1461-9. doi: 10.3855/jidc.4832.

25.

A multi-disciplinary approach to implementation science: the NIH-PEPFAR PMTCT implementation science alliance.

Sturke R, Harmston C, Simonds RJ, Mofenson LM, Siberry GK, Watts DH, McIntyre J, Anand N, Guay L, Castor D, Brouwers P, Nagel JD.

J Acquir Immune Defic Syndr. 2014 Nov 1;67 Suppl 2:S163-7. doi: 10.1097/QAI.0000000000000323.

PMID:
25310124
26.

Identification and characterization of MUS81 point mutations that abolish interaction with the SLX4 scaffold protein.

Nair N, Castor D, Macartney T, Rouse J.

DNA Repair (Amst). 2014 Dec;24:131-137. doi: 10.1016/j.dnarep.2014.08.004. Epub 2014 Sep 16.

27.

Lessons learned from scale-up of voluntary medical male circumcision focusing on adolescents: benefits, challenges, and potential opportunities for linkages with adolescent HIV, sexual, and reproductive health services.

Njeuhmeli E, Hatzold K, Gold E, Mahler H, Kripke K, Seifert-Ahanda K, Castor D, Mavhu W, Mugurungi O, Ncube G, Koshuma S, Sgaier S, Conly SR, Kasedde S.

J Acquir Immune Defic Syndr. 2014 Jul 1;66 Suppl 2:S193-9. doi: 10.1097/QAI.0000000000000179. Review.

PMID:
24918595
28.

Surgical efficiencies and quality in the performance of voluntary medical male circumcision (VMMC) procedures in Kenya, South Africa, Tanzania, and Zimbabwe.

Rech D, Bertrand JT, Thomas N, Farrell M, Reed J, Frade S, Samkange C, Obiero W, Agot K, Mahler H, Castor D, Njeuhmeli E.

PLoS One. 2014 May 6;9(5):e84271. doi: 10.1371/journal.pone.0084271. eCollection 2014.

29.

Work experience, job-fulfillment and burnout among VMMC providers in Kenya, South Africa, Tanzania and Zimbabwe.

Perry L, Rech D, Mavhu W, Frade S, Machaku MD, Onyango M, Aduda DS, Fimbo B, Cherutich P, Castor D, Njeuhmeli E, Bertrand JT.

PLoS One. 2014 May 6;9(5):e84215. doi: 10.1371/journal.pone.0084215. eCollection 2014.

30.

Costs and impacts of scaling up voluntary medical male circumcision in Tanzania.

Menon V, Gold E, Godbole R, Castor D, Mahler H, Forsythe S, Ally M, Njeuhmeli E.

PLoS One. 2014 May 6;9(5):e83925. doi: 10.1371/journal.pone.0083925. eCollection 2014.

31.

Voluntary medical male circumcision (VMMC) in Tanzania and Zimbabwe: service delivery intensity and modality and their influence on the age of clients.

Ashengo TA, Hatzold K, Mahler H, Rock A, Kanagat N, Magalona S, Curran K, Christensen A, Castor D, Mugurungi O, Dhlamini R, Xaba S, Njeuhmeli E.

PLoS One. 2014 May 6;9(5):e83642. doi: 10.1371/journal.pone.0083642. eCollection 2014.

32.

Provider attitudes toward the voluntary medical male circumcision scale-up in Kenya, South Africa, Tanzania and Zimbabwe.

Mavhu W, Frade S, Yongho AM, Farrell M, Hatzold K, Machaku M, Onyango M, Mugurungi O, Fimbo B, Cherutich P, Rech D, Castor D, Njeuhmeli E, Bertrand JT.

PLoS One. 2014 May 6;9(5):e82911. doi: 10.1371/journal.pone.0082911. eCollection 2014.

33.

Cost analysis of integrating the PrePex medical device into a voluntary medical male circumcision program in Zimbabwe.

Njeuhmeli E, Kripke K, Hatzold K, Reed J, Edgil D, Jaramillo J, Castor D, Forsythe S, Xaba S, Mugurungi O.

PLoS One. 2014 May 6;9(5):e82533. doi: 10.1371/journal.pone.0082533. eCollection 2014.

34.

Systematic Monitoring of Voluntary Medical Male Circumcision Scale-up: adoption of efficiency elements in Kenya, South Africa, Tanzania, and Zimbabwe.

Bertrand JT, Rech D, Omondi Aduda D, Frade S, Loolpapit M, Machaku MD, Oyango M, Mavhu W, Spyrelis A, Perry L, Farrell M, Castor D, Njeuhmeli E.

PLoS One. 2014 May 6;9(5):e82518. doi: 10.1371/journal.pone.0082518. eCollection 2014.

35.

Implications of the fast-evolving scale-up of adult voluntary medical male circumcision for quality of services in South Africa.

Rech D, Spyrelis A, Frade S, Perry L, Farrell M, Fertziger R, Toledo C, Castor D, Njeuhmeli E, Loykissoonlal D, Bertrand JT.

PLoS One. 2014 May 6;9(5):e80577. doi: 10.1371/journal.pone.0080577. eCollection 2014.

36.

Quality of voluntary medical male circumcision services during scale-up: a comparative process evaluation in Kenya, South Africa, Tanzania and Zimbabwe.

Jennings L, Bertrand J, Rech D, Harvey SA, Hatzold K, Samkange CA, Omondi Aduda DS, Fimbo B, Cherutich P, Perry L, Castor D, Njeuhmeli E.

PLoS One. 2014 May 6;9(5):e79524. doi: 10.1371/journal.pone.0079524. eCollection 2014.

37.

Distinct functional roles for the two SLX4 ubiquitin-binding UBZ domains mutated in Fanconi anemia.

Lachaud C, Castor D, Hain K, Muñoz I, Wilson J, MacArtney TJ, Schindler D, Rouse J.

J Cell Sci. 2014 Jul 1;127(Pt 13):2811-7. doi: 10.1242/jcs.146167. Epub 2014 May 2.

38.

Building the evidence base for urgent action: HIV epidemiology and innovative programming for men who have sex with men in sub-Saharan Africa.

Wolf RC, Cheng AS, Kapesa L, Castor D.

J Int AIDS Soc. 2013 Dec 2;16 Suppl 3:18903. doi: 10.7448/IAS.16.4.18903.

39.

Cooperative control of holliday junction resolution and DNA repair by the SLX1 and MUS81-EME1 nucleases.

Castor D, Nair N, Déclais AC, Lachaud C, Toth R, Macartney TJ, Lilley DM, Arthur JS, Rouse J.

Mol Cell. 2013 Oct 24;52(2):221-33. doi: 10.1016/j.molcel.2013.08.036. Epub 2013 Sep 26.

40.

Localization-dependent and -independent roles of SLX4 in regulating telomeres.

Wilson JS, Tejera AM, Castor D, Toth R, Blasco MA, Rouse J.

Cell Rep. 2013 Sep 12;4(5):853-60. doi: 10.1016/j.celrep.2013.07.033. Epub 2013 Aug 29.

41.

"Man, what took you so long?" Social and individual factors affecting adult attendance at voluntary medical male circumcision services in Tanzania.

Plotkin M, Castor D, Mziray H, Küver J, Mpuya E, Luvanda PJ, Hellar A, Curran K, Lukobo-Durell M, Ashengo TA, Mahler H.

Glob Health Sci Pract. 2013 Mar 21;1(1):108-16. doi: 10.9745/GHSP-D-12-00037. eCollection 2013 Mar.

42.

Steady-state pharmacokinetics, cord blood concentrations, and safety of ritonavir-boosted fosamprenavir in pregnancy.

Cespedes MS, Castor D, Ford SL, Lee D, Lou Y, Pakes GE, Aberg JA.

J Acquir Immune Defic Syndr. 2013 Apr 15;62(5):550-4. doi: 10.1097/QAI.0b013e318285d918.

43.

Participation in research involving novel sampling and study designs to identify acute HIV-1 infection among minority men who have sex with men.

Rodriguez K, Castor D, Mah TL, Cook SH, Auguiste LM, Halkitis PN, Markowitz M.

AIDS Care. 2013;25(7):828-34. doi: 10.1080/09540121.2012.748164. Epub 2013 Jan 11.

44.

Noncanonical mismatch repair as a source of genomic instability in human cells.

Peña-Diaz J, Bregenhorn S, Ghodgaonkar M, Follonier C, Artola-Borán M, Castor D, Lopes M, Sartori AA, Jiricny J.

Mol Cell. 2012 Sep 14;47(5):669-80. doi: 10.1016/j.molcel.2012.07.006. Epub 2012 Aug 2. Erratum in: Mol Cell. 2017 Jul 6;67(1):162.

45.

Transmitted drug resistance and phylogenetic relationships among acute and early HIV-1-infected individuals in New York City.

Castor D, Low A, Evering T, Karmon S, Davis B, Figueroa A, LaMar M, Garmon D, Mehandru S, Markowitz M.

J Acquir Immune Defic Syndr. 2012 Sep 1;61(1):1-8. doi: 10.1097/QAI.0b013e31825a289b.

46.

The endonuclease Ankle1 requires its LEM and GIY-YIG motifs for DNA cleavage in vivo.

Brachner A, Braun J, Ghodgaonkar M, Castor D, Zlopasa L, Ehrlich V, Jiricny J, Gotzmann J, Knasmüller S, Foisner R.

J Cell Sci. 2012 Feb 15;125(Pt 4):1048-57. doi: 10.1242/jcs.098392. Epub 2012 Mar 7.

47.

Voluntary medical male circumcision: modeling the impact and cost of expanding male circumcision for HIV prevention in eastern and southern Africa.

Njeuhmeli E, Forsythe S, Reed J, Opuni M, Bollinger L, Heard N, Castor D, Stover J, Farley T, Menon V, Hankins C.

PLoS Med. 2011 Nov;8(11):e1001132. doi: 10.1371/journal.pmed.1001132. Epub 2011 Nov 29.

48.

Voluntary medical male circumcision: matching demand and supply with quality and efficiency in a high-volume campaign in Iringa Region, Tanzania.

Mahler HR, Kileo B, Curran K, Plotkin M, Adamu T, Hellar A, Koshuma S, Nyabenda S, Machaku M, Lukobo-Durrell M, Castor D, Njeuhmeli E, Fimbo B.

PLoS Med. 2011 Nov;8(11):e1001131. doi: 10.1371/journal.pmed.1001131. Epub 2011 Nov 29. Review.

49.

Voluntary medical male circumcision: strategies for meeting the human resource needs of scale-up in southern and eastern Africa.

Curran K, Njeuhmeli E, Mirelman A, Dickson K, Adamu T, Cherutich P, Mahler H, Fimbo B, Mavuso TK, Albertini J, Fitzgerald L, Bock N, Reed J, Castor D, Stanton D.

PLoS Med. 2011 Nov;8(11):e1001129. doi: 10.1371/journal.pmed.1001129. Epub 2011 Nov 29. Review.

50.

Proteome profiling suggests a pro-inflammatory role for plasma cells through release of high-mobility group box 1 protein.

Vettermann C, Castor D, Mekker A, Gerrits B, Karas M, Jäck HM.

Proteomics. 2011 Apr;11(7):1228-37. doi: 10.1002/pmic.201000491. Epub 2011 Feb 14.

PMID:
21319304

Supplemental Content

Loading ...
Support Center